Psyence Biomedical Ltd Stock Alpha and Beta Analysis
| PBM Stock | USD 1.62 0.05 3.18% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Psyence Biomedical Ltd. It also helps investors analyze the systematic and unsystematic risks associated with investing in Psyence Biomedical over a specified time horizon. Remember, high Psyence Biomedical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Psyence Biomedical's market risk premium analysis include:
Beta 2.23 | Alpha (1.68) | Risk 12.55 | Sharpe Ratio (0.09) | Expected Return (1.18) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Psyence |
Psyence Biomedical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Psyence Biomedical market risk premium is the additional return an investor will receive from holding Psyence Biomedical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Psyence Biomedical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Psyence Biomedical's performance over market.| α | -1.68 | β | 2.23 |
Psyence Biomedical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Psyence Biomedical's Buy-and-hold return. Our buy-and-hold chart shows how Psyence Biomedical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Psyence Biomedical Market Price Analysis
Market price analysis indicators help investors to evaluate how Psyence Biomedical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Psyence Biomedical shares will generate the highest return on investment. By understating and applying Psyence Biomedical stock market price indicators, traders can identify Psyence Biomedical position entry and exit signals to maximize returns.
Psyence Biomedical Return and Market Media
The median price of Psyence Biomedical for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 is 2.43 with a coefficient of variation of 52.33. The daily time series for the period is distributed with a sample standard deviation of 1.66, arithmetic mean of 3.17, and mean deviation of 1.36. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ASBM Responds to PCMA Put Patients First, Not PBM Profits | 12/10/2024 |
2 | Lawmakers Want To Break Up Healthcare Conglomerates, Force Shedding Of Pharmacies | 12/16/2024 |
3 | Psyence Biomed Highlights Recent Progress on Active Phase IIb Clinical Trial | 12/17/2024 |
4 | PharmPix Corp. Joins Forces With Mark Cuban Cost Plus Drug Company to Revolutionize Pharmacy Benefits | 12/18/2024 |
5 | Psyence Biomedical Regains Full Compliance with All Nasdaq Continued Listing Requirements | 12/23/2024 |
6 | Psyence Biomed Announces Closing of 2.0 Million Private Placement | 12/27/2024 |
7 | Pacific Booker Minerals Shares Up 35.2 percent Heres What Happened | 01/03/2025 |
8 | Psyence Biomedical Adjusts Financials for Reverse Stock Split - TipRanks | 01/23/2025 |
About Psyence Biomedical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Psyence or other stocks. Alpha measures the amount that position in Psyence Biomedical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Psyence Biomedical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Psyence Biomedical's short interest history, or implied volatility extrapolated from Psyence Biomedical options trading.
Build Portfolio with Psyence Biomedical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Psyence Biomedical Backtesting, Psyence Biomedical Valuation, Psyence Biomedical Correlation, Psyence Biomedical Hype Analysis, Psyence Biomedical Volatility, Psyence Biomedical History and analyze Psyence Biomedical Performance. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Psyence Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.